Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2013HepatologyOpen Access

New horizons in hepatitis C antiviral therapy with direct-acting antivirals

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAlessio AghemoHumanitas UniversityRFRaffaele De FrancescoUniversity of Milan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aghemo et al. (2013) studied this question.

synapsesocial.com/papers/6a753cea8d2049c8dd0364d0https://doi.org/10.1002/hep.26371
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment predictors of a sustained virologic response in hepatitis B and C2008 · 327 citations
  2. 2New Protease Inhibitors for the Treatment of Chronic Hepatitis C2012 · 192 citations
  3. 3New Insights into Structure and Replication of the Hepatitis C Virus and Clinical Implications2010 · 74 citations
  4. 4Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations2010 · 226 citations
  5. 5Treating hepatitis C: current standard of care and emerging direct‐acting antiviral agents2012 · 195 citations